Clinical Trial Update: Real-life Security and Efficacy of DAA-based Therapy in HCV/HIV-Coinfected Patients

View source ↗

Summary

This clinical trial update assesses the real-world safety and efficacy of direct-acting antiviral therapy for hepatitis C in patients coinfected with HIV.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C
• Human Immunodeficiency Virus Infection

Drugs mentioned

• DAA-based therapy (direct-acting antiviral therapy for hepatitis C)

Snippet

Sponsor: Valme University Hospital | Conditions: Hepatitis C, Chronic, Human Immunodeficiency Virus | Status: UNKNOWN